Tribun Health enters pharmaceutical market

April 27, 2022—Tribun Health, formerly Tribvn Healthcare, announced its expansion into the pharmaceutical market with the appointment of Loic Dartois as vice president of pharma. Dartois, who has more than fifteen years of experience in the pharmaceutical, clinical development, and real-world evidence industries, joined Tribun Health in March and is developing commercial offerings for the pharma industry.

“Digital pathology data combined with best-in-class AI models has the power to improve treatments’ responses to a better targeted population,” Dartois said in a press release. “Thanks to its growing footprint in health care institutions in Europe and North America, Tribun Health is best positioned to support the pharmaceutical industry in its precision medicine transformation using an industry-leading digital pathology platform and deploying a thought leadership AI team.”

Tribun Health offers digital pathology workflow solutions in image acquisition, image storage and organization, web-based image management systems, image analysis using Al-powered deep and machine learning algorithms, and remote case sharing with peer review and reporting.